TLR9 and inflammatory bowel disease: Dextran sulfate sodium (DSS)-colitis, an experimental mouse model of inflammatory bowel disease (IBD), is particularly useful for studying the contributions of the innate immune system (including TLR9-signaling) to the pathomechanism and therapy of colitis [171,172].